GlassScriptPhysician profile
Kelly Cole
NPI 1700556818
$5,214.19
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.45 · 2022: $2,488 · 2023: $2,499 · 2024: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,663 · Education: $20.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,662.88 |
| Education | $20.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,420.48 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,215.30 | 2022-2024 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $756.10 | 2021-2023 | Entyvio, Gattex |
| Gilead Sciences, INC. | $347.64 | 2022-2024 | |
| Janssen Biotech, INC. | $228.16 | 2022-2023 | Stelara |
| Genzyme Corporation | $223.84 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $192.53 | 2022-2023 | Dificid, Zinplava |
| Kerecis Limited | $98.53 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Nestle Healthcare Nutrition INC. | $75.98 | 2022-2023 | |
| Ardelyx, INC. | $75.59 | 2023 | Ibsrela |
| Organon LLC | $66.02 | 2022-2023 | Hadlima, Renflexis |
| Regeneron Healthcare Solutions, INC. | $64.55 | 2022-2023 | Dupixent |
| Intercept Pharmaceuticals, INC. | $61.52 | 2022-2023 | Ocaliva |
| Pfizer INC. | $59.58 | 2023 | |
| Alnylam Pharmaceuticals INC. | $50.48 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $49.09 | 2022-2023 | Prevena, V.A.C. Veraflo |
| Redhill Biopharma INC. | $48.60 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $39.10 | 2022-2023 | |
| Ironwood Pharmaceuticals, INC | $28.71 | 2023 | Linzess |
| Eisai INC. | $24.95 | 2022 | |
| Medline Industries LP | $24.39 | 2022 | |
| Mallinckrodt Hospital Products INC. | $22.60 | 2023 | Stratagraft |
| Celltrion USA INC. | $20.53 | 2023 | Yuflyma |
| Sandoz INC. | $19.92 | 2023 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.